Characterization of a rabbit osteoporosis model induced by ovariectomy and glucocorticoid.
OBJECTIVE
Experimental models of osteoporosis in rabbits are useful to investigate anabolic agents because rabbits have an active Haversian remodeling and achieve skeletal maturity quickly. In this study, an experimental model of osteoporosis in rabbits induced by a combination of ovariectomy and glucocorticoid was characterized to provide a useful model for prevention and therapy of osteoporosis.


METHODS
32 skeletally mature female rabbits were divided randomly into 4 groups: sham control, bilateral ovariectomy (OVX), 1mg/kg/day methylprednisolone (MP) for 8 weeks, and OVX in combination with MP. All rabbits were killed 10 weeks after surgery. Bone mineral density (BMD) of lumbar spine was measured by dual-energy X-ray absorptiometry at baseline, and at 6 and 10 weeks postoperatively. Bone microarchitecture and mechanical properties of lumbar vertebrae were investigated by high-resolution micro-computed tomography and compression test, respectively, after killing.


RESULTS
Mean BMD of the OVX+MP group at 10 weeks was reduced by about 36% from baseline (p < 0.001). Bone microarchitecture of lumbar vertebrae in the OVX+MP group indicated osteoporosis-associated deterioration. There was a statistically significant reduction in maximum load, stiffness, and energy absorption capacity of lumbar vertebrae in the OVX+MP group, but not in the OVX group, compared to the sham control. In the MP group, BMD and some microarchitecture parameters such as trabecular thickness and bone volume fraction were reduced. The mechanical properties were not statistically significantly different from those in the sham control group, however, although a negative trend was observed.


CONCLUSIONS
Osteopenia can be induced experimentally in rabbits through a combination of OVX and MP, and can be evaluated by BMD, bone microstructure, and mechanical parameters.
Baofeng
Li
L
Department of Orthopaedics, Guangzhou General Hospital of Guangzhou Military Command, Guangzhou.
Zhi
Yuan
Y
Bei
Chen
C
Guolin
Meng
M
Qingshui
Yin
Y
Jian
Liu
L
D000818:Animals; D015519:Bone Density / Q000187:drug effects; D004195:Disease Models, Animal; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage; D008775:Methylprednisolone / Q000008:administration & dosage; D010024:Osteoporosis / Q000175:diagnosis / Q000209:etiology / Q000473:pathology / Q000628:therapy; D010052:Ovariectomy; D011817:Rabbits
D005938:Glucocorticoids; D008775:Methylprednisolone
Comp Med. 2008 Oct;58(5):424-30
19004367
J Periodontal Res. 2004 Feb;39(1):37-41
14687226
Osteoporos Int. 2002;13(2):97-104
11905527
Metab Bone Dis Relat Res. 1983;4(5):319-24
6621357
Bone. 1993 May-Jun;14(3):369-77
8363880
Endocrinology. 2001 Mar;142(3):1333-40
11181552
Osteoporos Int. 1994 Jul;4(4):204-10
7949750
Bone. 1994 Sep-Oct;15(5):523-32
7980963
J Bone Miner Metab. 2008;26(1):53-9
18095064
Rev Endocr Metab Disord. 2001 Jan;2(1):117-27
11704974
Skeletal Radiol. 2006 Jan;35(1):34-41
16247642
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000 Feb;89(2):244-9
10673664
J Oral Maxillofac Surg. 1997 Apr;55(4):351-61; discussion 362
9120698
Bone. 1995 Apr;16(4 Suppl):277S-284S
7626315
Tissue Eng. 2006 Jul;12(7):1753-61
16889506
Bone. 1995 Oct;17(4 Suppl):125S-133S
8579908
Am J Physiol. 1988 Oct;255(4 Pt 1):E416-21
3177632
Bone. 2008 Jan;42(1):74-80
17942382
J Biomech. 2008;41(2):368-75
17953972
Bone Miner. 1991 Dec;15(3):175-91
1773131
Bone Miner. 1992 Sep;18(3):227-36
1392696
Bone. 1995 Oct;17(4 Suppl):343S-352S
8579937
Osteoporos Int. 2002 May;13(5):407-14
12086352
Bone. 2001 Jul;29(1):62-9
11472892
N Engl J Med. 1983 Aug 4;309(5):265-8
6866051